mots-c mastery course
Unit 5 of 10

exercise-induced and exercise-mimetic

the 2021 Nature Communications paper, in detail

when the same peptide rises with exercise and falls with age

the paper

In 2021 Joseph Reynolds, Ricardo Lai, Jonathan Woodhead, and Changhan Lee's group published a landmark Nature Communications paper that anchored the exercise-mimetic framing of MOTS-c. They showed two related findings in one paper. First, MOTS-c rises in muscle and circulation during exercise in both mice and humans. Second, MOTS-c declines with age, and pharmacologically restoring it in aged mice rescued treadmill performance.

what this unit is for

This is the paper most often cited when people talk about MOTS-c as "exercise in a bottle." That phrase is a hypothesis-level shortcut, not a clinical claim. This unit walks through what the paper actually shows, where the human data fits, and how to talk about exercise-mimetic biology without overselling it.

Exercise-induced and exercise-mimetic are two separate claims. Reynolds 2021 supports both, but with different evidence weights. The human exercise-induction data is real; the human exercise-replacement claim is hypothesis-level.

at a glance

the load-bearing facts for this unit.

2021
Reynolds et al., Nature Communications
aged mice
pharmacologic MOTS-c rescued treadmill performance
exercise-induced
levels rise with exercise in mice and humans
age decline
falls with chronological aging

aged-mouse treadmill explorer

drag the slider to compare young vs aged vs aged-plus-MOTS-c performance on the Reynolds 2021 treadmill protocol. the takeaway is that pharmacologic MOTS-c partially rescues the aged-mouse endurance deficit, pushing performance back toward (though not all the way to) the trained-aged baseline -- which is the central preclinical finding the entire "exercise mimetic" framing rests on.

aged-mouse treadmill explorer

exercise ↔ MOTS-c overlap explorer

switch tabs between where MOTS-c genuinely overlaps real exercise and where it does not. the honest read: MOTS-c shares the metabolic machinery of exercise -- AMPK activation, fat oxidation, mitochondrial adaptation -- but reproduces none of the cardiovascular load, mechanical strength stimulus, or VO2max and skill gains that come from actually moving. click any row for the mechanism and the caveat.

exercise overlap explorer

key terms

definitions you will encounter throughout this unit.

Eexercise mimeticdrug class
A compound that reproduces some of the cellular adaptations of exercise without the exercise. A hypothesis-level concept, not a clinical category of drug yet. Used to describe AICAR, GW1516, and -- in some preclinical contexts -- MOTS-c.
Mmitokinepeptide
A mitochondria-derived signal with systemic effects. MOTS-c is grouped with mitokines because it circulates and acts on distant tissues including muscle, liver, and adipose.
Sskeletal muscleanatomy
The voluntary striated muscle that drives movement. Accounts for ~40% of body mass in healthy adults and is the major site of insulin-stimulated glucose disposal. A primary tissue where MOTS-c biology has been studied.
Ttreadmill capacity testtrial design
A standardized preclinical assay where mice run on a treadmill until exhaustion. Distance to exhaustion is a quantitative readout of aerobic and metabolic capacity. Used in Reynolds 2021 to measure MOTS-c-driven performance rescue in aged mice.
Aage-dependent declinemechanism
A biological process whose magnitude or quality reduces with chronological aging. Relevant here because circulating and muscle MOTS-c falls with age, providing a hypothesis for how a peptide could rescue age-related functional decline.
Iinducible signalmechanism
A signal whose levels rise in response to a stimulus rather than staying constant. MOTS-c is described as exercise-inducible based on rising muscle and blood levels after exercise sessions in animal and human studies.

simple version first, advanced detail below

the plain-English read on this unit's mechanism, with technical depth on demand.

the pattern

The simple version: MOTS-c goes up when you exercise and down when you age. Reynolds 2021 showed this pattern in mouse muscle and in human blood drawn before and after exercise.

the rescue experiment

Then they did the obvious follow-up experiment: take old mice with low MOTS-c, give them a pharmacologic dose, and see if their treadmill performance improves. It did -- substantially. That is the basis of the exercise-mimetic claim.

what it doesn't show

What it does not show is that humans get the same rescue from injected MOTS-c. No comparably designed human trial exists. The framing "exercise in a bottle" is provocative shorthand for a preclinical pattern, not a clinical claim. Interpret accordingly.

Aadvanced: the Reynolds 2021 treadmill protocolterm
Aged C57BL/6 mice (~22 months, roughly equivalent to ~70-75 human years) were divided into a control group, an exercise-trained group, and a group given pharmacologic MOTS-c by intraperitoneal injection. The readout was distance run on an enclosed treadmill until volitional exhaustion (defined by inability to continue despite gentle prodding). The MOTS-c-treated aged mice ran significantly farther than untreated aged controls, with effect sizes that approached the trained-aged group in some experiments. Parallel mechanistic work showed that the rescued performance tracked with restored mitochondrial respiration, AMPK activation, and metabolic-flexibility markers in skeletal muscle.
Aadvanced: human MOTS-c exercise induction, what was actually measuredterm
The human side of Reynolds 2021 measured plasma MOTS-c by enzyme-linked immunosorbent assay (ELISA) before and after an acute exercise bout. Levels rose post-exercise, supporting the "MOTS-c is exercise-induced" claim. Important nuances: ELISAs for small peptides are sensitive to antibody specificity, sample handling, and freeze-thaw cycling -- different cohorts using different assays sometimes report opposite directional changes (a 2026 paper by Yoon et al. shows higher circulating MOTS-c in obese adults, not lower). Assay harmonization is an open methodological problem in MOTS-c human research, covered in more detail in unit 8.

exercise mimetic claim quality

three claims, three evidence weights, color-coded by how much support they actually have.

solid MOTS-c rescues aged-mouse treadmill performance
  • Reynolds 2021 treadmill rescue is real and replicated
  • mechanism aligns with AMPK / mitochondrial biology
  • aged mice are an established sarcopenia/decline model
  • the strongest single piece of "MOTS-c does exercise things" evidence
moderate human exercise induction (inducibility, not replacement)
  • exercise-induced rise in plasma documented (mostly small cohorts)
  • ELISA assay variability across cohorts complicates interpretation
  • good support for "MOTS-c is exercise-inducible in humans"
  • insufficient for any clinical-replacement claim
hypothesis "exercise in a bottle" framing in humans
  • communication shorthand, not a clinical claim
  • no compound has cleared the bar for human exercise replacement
  • overuse of the phrase distorts how the evidence is read
  • better framing: "exercise-responsive mitochondrial peptide with mimetic features in preclinical models"
The exercise-mimetic claim is preclinical, not clinical. The aged-mouse data is the cleanest piece of evidence in the entire MOTS-c file. The human-replacement claim is hypothesis-level. Read accordingly and avoid quoting "exercise in a bottle" as if it were a clinical finding.